<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112464856</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112464856</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Seeing a Difference in <italic>C. diff</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tappenden</surname><given-names>Kelly A.</given-names></name>
<degrees>PhD, RD</degrees>
</contrib>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>36</volume>
<issue>6</issue>
<fpage>625</fpage>
<lpage>625</lpage>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>With the 2012 presidential election at its peak as this issue of <italic>JPEN</italic> arrives in your mailbox, much debate on the Affordable Care Act has recently occurred. What is not debatable is that <italic>Clostridium difficile</italic> is a difficult-to-manage healthcare-associated infection. Indeed, hospitalizations with C. <italic>difficile</italic> as a diagnosis have skyrocketed &gt;3-fold over the past 20 years in the United States.<sup><xref ref-type="bibr" rid="bibr1-0148607112464856">1</xref></sup> Altruistic interest in quality care, in addition to regulatory and financial pressures imposed by the Affordable Care Act, motivate the search for solutions to this problem. It’s a concern that will not go away until this deadly pathogen is stopped.</p>
<p>Resources to help this effort are available. The National Healthcare Safety Network has an up-to-date detailed protocol.<sup><xref ref-type="bibr" rid="bibr2-0148607112464856">2</xref></sup> In addition, the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Disease Society of America (IDSA) have published well-utilized clinical guidelines.<sup><xref ref-type="bibr" rid="bibr3-0148607112464856">3</xref></sup> However, given this prevalent problem, widespread knowledge and implementation of these recommended approaches are also needed.</p>
<p>Knowledge, attitudes, and practice regarding <italic>Clostridium difficile</italic> were recently surveyed by Fayerberg and associates<sup><xref ref-type="bibr" rid="bibr4-0148607112464856">4</xref></sup> within a large academic medical center. Significant gaps in knowledge and practice among physician responders were identified. Gaps in knowledge existed in multiple areas ranging from diagnosis through treatment, compared with the published clinical guidelines and the institution’s own policy. Other reports indicate that this knowledge gap is not unique to this facility, but also exists among US internal medicine residents<sup><xref ref-type="bibr" rid="bibr5-0148607112464856">5</xref></sup>, practicing pediatricians<sup><xref ref-type="bibr" rid="bibr6-0148607112464856">6</xref></sup>, and various groups of clinicians in the United Kingdom.<sup><xref ref-type="bibr" rid="bibr7-0148607112464856">7</xref></sup></p>
<p>With this knowledge gap in mind, this issue of <italic>JPEN</italic> contains an Invited Review by Dr. Edmiston and colleagues, titled, “<italic>Clostridium difficile</italic>: Epidemiology, Pathogenesis, Manage-ment, and Prevention of a Recalcitrant Healthcare-Associated Pathogen.”<sup><xref ref-type="bibr" rid="bibr8-0148607112464856">8</xref></sup> This comprehensive review will serve as a go-to reference for critical knowledge spanning microbial virulence through infection management and prevention.</p>
<p>As efforts continue to combat this difficult healthcare-associated pathogen, do keep abreast of advances in knowledge. Since the review by Dr. Edmiston’s group was published online, new relevant publications have appeared in the literature regarding alternative therapies in the early stage of study. A large meta-analysis by Hempel and associates<sup><xref ref-type="bibr" rid="bibr9-0148607112464856">9</xref></sup>, including 63 randomized controlled trials with 11,811 participants, disclose pooled evidence indicating that probiotics are associated with a reduction in antibiotic-associated diarrhea. Additional study is needed to determine specific impact among various populations, inciting antibiotic and probiotic preparation.</p>
<p>A Canadian working group with members spanning a broad range of expertise recently published a report on fecal microbial therapy with a specific emphasis on the treatment of <italic>C. difficile</italic> colitis.<sup><xref ref-type="bibr" rid="bibr10-0148607112464856">10</xref></sup> The report highlights the promise of “microbial ecosystems therapeutics” (MET), in addition to identifying pressing clinical issues as well as social, ethical, and regulatory barriers. These investigators make a case for the following four priorities for future studies: (1) obtaining better <italic>C. difficile</italic> epidemiological data; (2) establishing improved and more standardized methods for detecting recurrent <italic>C. difficile</italic> infection; (3) standardizing donor screening; and (4) standardizing MET preparation and administration. Further, a need for understanding the implications of diet, other gastrointestinal colonizing pathogens, preexisting diagnoses, and synthetic stool transplants are also discussed.</p>
<p>Beyond desire and willpower, overcoming the challenge of <italic>C. difficile</italic> infection will require widespread education, systematic implementation of guidelines and protocols, and strategic research efforts.</p>
<p>Educate yourself, watch for new knowledge in the literature, and engage in the conversation.</p>
<sig-block>
<sig><italic>JPEN</italic>, Editor-in-Chief</sig>
</sig-block>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112464856">
<label>1.</label>
<citation citation-type="gov">
<article-title>Hospital stays involving <italic>C. difficile</italic> infections leveled off after 300 percent increase since 1993</article-title>. AHRQ News and Numbers, <month>January</month> <day>25</day>, <year>2012</year>. <publisher-name>Agency for Healthcare Research and Quality</publisher-name>, <publisher-loc>Rockville, MD</publisher-loc>. <ext-link ext-link-type="uri" xlink:href="http://www.ahrq.gov/news/nn/nn012512.htm">http://www.ahrq.gov/news/nn/nn012512.htm</ext-link></citation>
</ref>
<ref id="bibr2-0148607112464856">
<label>2.</label>
<citation citation-type="gov">
<collab>Centers for Disease Control and Prevention</collab>. <article-title>Multidrug-resistant organism and <italic>Clostridium difficile</italic> infection (MDRO/CDI) module protocol</article-title>, <month>January</month> <year>2012</year>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nhsn/mdro_cdad.html">http://www.cdc.gov/nhsn/mdro_cdad.html</ext-link>, <access-date>Accessed September 25, 2012</access-date>.</citation>
</ref>
<ref id="bibr3-0148607112464856">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>SH</given-names></name>
<name><surname>Gerding</surname><given-names>DN</given-names></name>
<name><surname>Johnson</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Clinical practice guidelines for <italic>Clostridium difficile</italic> infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Disease Society of America (IDSA)</article-title>. <source>Infect Control Hosp Epidemiol</source> <year>2010</year>;<volume>31</volume>:<fpage>431</fpage>-<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112464856">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fayerberg</surname><given-names>E</given-names></name>
<name><surname>Bouchard</surname><given-names>J</given-names></name>
<name><surname>Kellie</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Knowledge, attitudes and practice regarding <italic>Clostridium difficile</italic>: a survey of physicians in an academic medical center</article-title>. <year>2012</year> <month>Sep</month> <day>13</day>. pii: S0196-6553(12)00767-5. doi: <pub-id pub-id-type="doi">10.1016/j.ajic.2012.03.013</pub-id>. [Epub ahead of print]</citation>
</ref>
<ref id="bibr5-0148607112464856">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muto</surname><given-names>CA</given-names></name>
<name><surname>Blank</surname><given-names>MK</given-names></name>
<name><surname>Marsh</surname><given-names>JW</given-names></name><etal/>
</person-group>. <article-title>Control of an outbreak of infection with the hypervirulent <italic>Clostridium difficile</italic> B1 strain in a university hospital using a comprehensive ‘bundle’ approach</article-title>. <source>Clin Infect Dis</source> <year>2007</year>;<volume>45</volume>:<fpage>1266</fpage>-<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112464856">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klatte</surname><given-names>JM</given-names></name>
<name><surname>Myers</surname><given-names>AL</given-names></name>
<name><surname>Livingston</surname><given-names>RA</given-names></name>
<name><surname>Jackson</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Pediatric physicians’ knowledge, attitudes, and beliefs regarding <italic>Clostridium difficile</italic>-associated disease prevention, testing, and treatment</article-title>. <source>Am J Inf Cont</source> <year>2012</year>;<volume>40</volume>:<fpage>577</fpage>.</citation>
</ref>
<ref id="bibr7-0148607112464856">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Navaneethan</surname><given-names>U</given-names></name>
<name><surname>Schauer</surname><given-names>D</given-names></name>
<name><surname>Giannella</surname><given-names>R</given-names></name>
</person-group>. <article-title>Awareness about <italic>Clostridium difficile</italic> infection among internal medicine residents in the United States</article-title>. <source>Minerva Gastroenterol Dietol</source> <year>2011</year>;<volume>57</volume>:<fpage>231</fpage>-<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112464856">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Badger</surname><given-names>VO</given-names></name>
<name><surname>Ladeboer</surname><given-names>NA</given-names></name>
<name><surname>Graham</surname><given-names>MB</given-names></name>
<name><surname>Edmiston</surname><given-names>CE</given-names></name>
</person-group>. <article-title><italic>Clostridium difficile</italic>: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2012</year>;<volume>36</volume>:<fpage>645</fpage>-<lpage>662</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112464856">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hempel</surname><given-names>S</given-names></name>
<name><surname>Newberry</surname><given-names>SJ</given-names></name>
<name><surname>Maher</surname><given-names>AR</given-names></name><etal/>
</person-group>. <article-title>Probiotics for the prevention and treatment of antibiotic-associated diarrhea</article-title>. <source>JAMA</source> <year>2012</year>;<volume>307</volume>:<fpage>1959</fpage>-<lpage>1969</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112464856">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Allen-Vercoe</surname><given-names>E</given-names></name>
<name><surname>Reid</surname><given-names>G</given-names></name>
<name><surname>Viner</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics</article-title>. <source>Can J Gastroenterol</source> <year>2012</year>;<volume>26</volume>:<fpage>457</fpage>-<lpage>462</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>